Olympic Cool-Cap System Recall: Software Problems During Treatment

A medical head-cooling system for newborns is being recalled because of a software problem, which may cause it to fail while treating infants. 

The Olympic Cool-Cap System recall was announced by the FDA on December 12, impacting selective head cooling systems for full-term infants suffering from hypoxic-ischemic encephalopathy (HIE), which are manufactured by Natus Medical.

Natus originally sent out an Urgent: Medical Device letter to its customers in May, alerting them that the screen on the Control Module of the device can freeze. This means that despite information being shown on-screen that the caps are working, the infant may not be receiving cooling treatment.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

This week the FDA determined that the letter constituted a Class I medical device recall, the highest designation a recall can receive. The Class I designation means that the FDA believes the cooling cap problem creates the reasonable probability that a patient will suffer severe injury or death. However, there have been no injuries or deaths reported in relation to the Olympic Cool-Cap problems.

The recall affects the Olympic Cool-Cap System, catalog/part number 60010, distributed between January 18, 2007 through April 20, 2012. The recall affects all serial numbers.

The caps are cooling water caps placed on the head of the infant while the body is warmed with radiant warmers. When working properly the caps provide 72 hours of monitored cooling for moderate to severe cases of HIE to prevent or reduce neurologic injury.

Customers with questions should contact Natus Technical Service at (888)496-2887.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Women who experienced infection, chronic inflammation, implant instability or other complications after internal bra mesh procedures are now questioning whether those risks were fully disclosed before implantation.
More than 3,300 women have filed Depo-Provera lawsuits in federal court, with several hundred more also pending in state courts in New York and Delaware, according to a recent status report.